Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H18FN3.2ClH |
Molecular Weight | 368.276 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.FC1=CC2=C(NC3=C2CN(CCC4=CC=NC=C4)CC3)C=C1
InChI
InChIKey=JZKBIAMJBKEKGP-UHFFFAOYSA-N
InChI=1S/C18H18FN3.2ClH/c19-14-1-2-17-15(11-14)16-12-22(10-6-18(16)21-17)9-5-13-3-7-20-8-4-13;;/h1-4,7-8,11,21H,5-6,9-10,12H2;2*1H
Carvotroline [WY 47791] is a novel γ-carboline derivative with a preclinical profile suggestive of antipsychotic activity. Carvotroline has an affinity for the dopamine D2 receptor and cortical 5-HT2 receptor that is ten times greater than serotonin. Carvotroline administration to rats leads to a decrease of plasma corticosterone levels and demonstrated a moderating effect on the rotational-stress induced rise in plasma corticosterone levels.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9323305
rat 7.0 mg/kg
Route of Administration:
Intraperitoneal
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
13772459
Created by
admin on Fri Dec 15 15:58:02 GMT 2023 , Edited by admin on Fri Dec 15 15:58:02 GMT 2023
|
PRIMARY | |||
|
WGF75067BR
Created by
admin on Fri Dec 15 15:58:02 GMT 2023 , Edited by admin on Fri Dec 15 15:58:02 GMT 2023
|
PRIMARY | |||
|
DTXSID70147991
Created by
admin on Fri Dec 15 15:58:02 GMT 2023 , Edited by admin on Fri Dec 15 15:58:02 GMT 2023
|
PRIMARY | |||
|
107266-20-6
Created by
admin on Fri Dec 15 15:58:02 GMT 2023 , Edited by admin on Fri Dec 15 15:58:02 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD